Saluja Dipender

Director Saluja sold 3,297,645 shares (25% of holdings) for $36.9M at $11.20 blended average; stock now $10.84, down 41.2% from 52-week high.

Director Dipender Saluja executed 2 separate sales totaling 3,297,645 shares for $36,943,678.77, reducing his stake from 13,190,579 shares to 9,892,934 shares (a 25.0% reduction). The sales occurred at a blended average price of $11.20, while the stock now trades at $10.84 and is down 41.2% from its 52-week high of $18.44. QuantumScape remains unprofitable with a net income of $-105,824,000.00 over its most recent full fiscal year. Notably, Saluja's cross-ticker track record shows a 90-day well-timed rate of 100.00%, indicating his prior sells across all holdings have consistently preceded stock declines, though this historical accuracy does not necessarily predict this specific transaction's outcome.

Director Saluja sold 1.19M shares (20% of holdings) for $9.8M; stock down 54.2% from 52-week high despite insider's 100% sell-timing accuracy at NVTS.

Saliju Dipender (Director) executed two separate sales totaling 1,188,884 shares for $9,803,428.20 (blended average $8.25), reducing holdings by 20.0% from 5,944,420 to 4,755,536 shares. The timing is notable: Saluja's prior 5 sales at NVTS were all well-timed at the 90-day mark, with every sale followed by 30–47% declines. His cross-ticker track record shows a 100.00% 90-day well-timed rate across 13 prior sells. Against this backdrop, the current stock price ($7.83) sits 54.2% below the 52-week high ($17.10) and trades below his transaction prices ($8.25 blended)—consistent with the historical pattern. The company remains unprofitable (net income $-19,234,000) with modest revenue growth (+4.8% annual), providing limited operational tailwind. The director's sustained and disciplined sell pattern, combined with depressed fundamentals, warrants investor attention to divergence between insider actions and near-term price momentum.